Interstitial Lung Disease and Esophageal Disorders: When Specialties Work Together
Jan 2, 2024
auto_awesome
Dr. Rita Knotts and Dr. Elizabeth Volkmann discuss the intersection of their specialties in the care of patients with scleroderma, interstitial lung disease, and esophageal conditions. They explore the relationship between reflux disease and lung function, concerns and risks of proton pump inhibitors, the multidisciplinary model for interstitial lung disease and scleroderma, and the collaboration between surgeons and gastroenterologists in managing esophageal disorders.
Patient-reported symptoms of reflux disease in scleroderma patients with interstitial lung disease may be associated with ILD progression.
Assessing esophageal motility over time may be more meaningful than a single measurement of esophageal dilation in predicting ILD progression.
Deep dives
Patients with scleroderma-related ILD experienced improvement in FBC with treatments, but some still had progression
The podcast discusses a study that focused on patients with scleroderma-related interstitial lung disease (ILD). The study, called the scleroderma lung study, examined the effectiveness of oral cyclophosphamide and mycophenolate as treatments. While many patients in the study saw improvement in their Forced Vital Capacity (FVC), some continued to experience ILD progression. The researchers aimed to understand the factors that may predict this progression, with a particular focus on the severity of esophageal disease.
Patient-reported esophageal symptoms were associated with ILD progression
The podcast discusses how patient-reported symptoms of reflux disease were analyzed in relation to the progression of ILD. The study used the UCLA GIT 2.0 questionnaire to assess the severity of esophageal symptoms. The scores from this assessment were then correlated with the radiological progression of ILD. Interestingly, the study found that patient-reported symptoms were associated with more ILD progression. However, the measurement of esophageal dilation did not show a correlation with progression. The researchers suggest that a single measurement of dilation may not be as meaningful as assessing esophageal motility over time.
Gastroenterologists' role in the multidisciplinary care of scleroderma patients
The podcast explores the benefits of a multidisciplinary approach in treating scleroderma patients, emphasizing the collaborative efforts of gastroenterologists, rheumatologists, pulmonologists, radiologists, and pathologists. The care team at UCLA, for example, includes motility-focused gastroenterologists who contribute valuable insights. The discussion touches on the importance of considering reflux surgery in certain cases, such as patients evaluated for lung transplantation or those who are not responding to medical therapy. The decision-making process for surgery involves close collaboration and careful consideration of the patient's overall condition and needs.
In this special podcast Dr Rita Knotts, with the Center for Esophageal Health at NYU-Langone, and Dr Elizabeth Volkmann, founder and codirector of the UCLA Connective Tissue Disease-Related Interstitial Lung Disease, discuss the intersection of their specialities in the care of patients with scleroderma, interstitial lung disease, and esophageal conditions such as reflux.
Get the Snipd podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered podcast player
Listen to all your favourite podcasts with AI-powered features
Discover highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share & Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered podcast player
Listen to all your favourite podcasts with AI-powered features
Discover highlights
Listen to the best highlights from the podcasts you love and dive into the full episode